Download Files:
20S Proteasome-IN-1
SKU
HY-139331-1 mg
Category Reference compound
Tags Cancer; Inflammation/Immunology; Neurological Disease, Metabolic Enzyme/Protease, Proteasome
$71 – $980
Products Details
Product Description
– 20S Proteasome-IN-1 is a 26S proteasome inhibitor extracted from patent WO2006128196A2 compound 2. 20S Proteasome-IN-1 has the potential for cancer, immune-related disorders, inflammation, ischemic conditions, neurodegenerative disorders and other diseases research[1].
Web ID
– HY-139331
Storage Temperature
– 4°C (Powder, protect from light)
Shipping
– Room Temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C23H25N3O4
References
– [1]Parlati F, et, al. Novel substrate for rpn 11 enzymatic activity. WO2006128196A2.
CAS Number
– 858557-69-4
Molecular Weight
– 407.46
Compound Purity
– 99.13
SMILES
– O=C(N1CCC(CC1)C2=NC(C3=CC=C(C)C=C3)=NO2)C4=C(OC)C=CC=C4OC
Clinical Information
– No Development Reported
Research Area
– Cancer; Inflammation/Immunology; Neurological Disease
Solubility
– DMSO : 31.25 mg/mL (ultrasonic;warming;heat to 60°C)
Target
– Proteasome
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.